As a worldwide leader in cardiovascular and neuromodulation solutions, we are dedicated to creating meaningful products and therapies that transform lives each and every day. It’s health innovation that truly matters.
LivaNova is a global medical technology company built on decades of experience and a relentless commitment to improve the lives of patients around the world. As a worldwide leader in cardiovascular and neuromodulation solutions, we are dedicated to helping create meaningful products and therapies that transform lives each and every day. LivaNova is also dedicated to the highest standards, and we operate at the topmost level of business ethics and compliance.
At LivaNova, we unite to provide hope for patients and their families through innovative medical technologies, delivering life-changing improvements for both the Head and Heart.
Patients First: Our shared purpose is to improve the lives of patients.
Meaningful Innovation: We develop novel products and therapies to address multiple disease states.
Act with Agility: We challenge ourselves to continuously improve and act nimbly.
Commitment to Quality and Integrity: We dedicate ourselves to high quality and integrity in everything we do.
Collaborative Culture: We value diversity of thought and our collective strength as a team.
As a strong, market-leading medical technology and solutions company, we understand the importance of bringing both clinical and economic value to our customers. LivaNova offers a diverse product portfolio with a differentiated pipeline. Our global reach is broad with a presence in more than 100 countries and approximately 4,000 employees.
LivaNova operates as two businesses:
We are a global leader in cardiovascular solutions with an established leadership position in heart-lung machines and recognition as the world’s #1 cardiopulmonary bypass company. Plus, we offer the only truly sutureless aortic valve replacement, Perceval®. Our advanced technologies have made significant contributions to cardiac surgery and provided positive outcomes for many patients who have needed cardiac and cardiopulmonary support.
As pioneers of the VNS (Vagus Nerve Stimulation) Therapy® System, we continue to advance medical device solutions for people affected by drug-resistant epilepsy and treatment-resistant depression. This System is also being studied to validate its ability to deliver Autonomic Regulation Therapy for heart failure. Additionally, we treat obstructive sleep apnea (OSA) with an implantable device that stimulates multiple tongue muscles via the hypoglossal nerve, opening the airway while a patient is sleeping.
Learn about a career at Livanova
Connecting to server. Please wait.
Thank you! We’ll be in touch.
Something went wrong. Please check your internet connection and try again.
The service you are trying to submit to is unavailable. Please try again at a later time.